Named clinics. Where the protocols actually run. The further down the table, the further outside FDA jurisdiction — and the more recently the molecule reached the patient. Click any row for services, treatments offered, and pricing tiers.
| Clinic | Country | Tier |
|---|
Off-label prescriptions, OTC supplements, and procedures running today. Evidence ranges from large RCT (GLP-1) to single-trial speculation (HBOT, exosomes). Read the rating before reading the headline.
| Sym | Asset | Status | Evidence |
|---|
The frontier. Five categories, fourteen named programs, $3B+ in known capital. First human reprogramming results expected 2026-2027. Where today's "speculative" becomes tomorrow's standard of care.
| Sym | Program | Phase |
|---|
Measure first or you're flying blind. Epigenetic clocks compress 20-year mortality studies into a 6-month feedback loop — the most important development in this guide.
| Test | Best option | Cost |
|---|